Clinical trial
PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic…
NCT00335296 · Cierra, Industry · Suspended
Key facts
| NCT number | NCT00335296 |
|---|---|
| Title | PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO) |
| Official title | The Paradigm IIca/III Trial: PFx Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness |
| Lead sponsor | Cierra, Industry |
| Status | Suspended |
| Study type | Interventional |
| Conditions | Patent Foramen Ovale |
| Intervention type | Device |
| Interventions | PFx catheter |
| Enrollment | 100 |
| Start date | May 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Jun 9, 2006 |
| Last update posted | Dec 24, 2007 |
| Countries | Belgium, France, Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: